Started in 2003, the first manufacturing facilities of Neopharma were planned on an investment outlay of US$25 million. Spread over an area of 100,000m2, the plant encompasses two independent production blocks – one dedicated for the manufacture of general products and the other, an exclusive centre for manufacturing betalactam products. In addition to the above, the plant has an exclusive area for the formulations Research ...
Started in 2003, the first manufacturing facilities of Neopharma were planned on an investment outlay of US$25 million. Spread over an area of 100,000m2, the plant encompasses two independent production blocks – one dedicated for the manufacture of general products and the other, an exclusive centre for manufacturing betalactam products. In addition to the above, the plant has an exclusive area for the formulations Research and Development block.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.